Same-class & cross-class optionsLive provider pricing

Rybelsus Alternatives & Comparison

Rybelsus (semaglutide) set beside Ozempic, Mounjaro, Trulicity: how each works, what its trials measured, what it costs, and who sells it.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

These are the drugs people weigh against Rybelsus. The Rybelsus drug guide covers Rybelsus itself, the Rybelsus cost page covers its price.

Rybelsus Alternatives Compared

OzempicSemaglutide · Novo Nordisk A/S

Same molecule. Ozempic tablets are the US replacement for Rybelsus (7 mg matches 4 mg, 14 mg matches 9 mg), and the weekly Ozempic injection is the other form

Ozempic activates GLP-1 receptors to stimulate glucose-dependent insulin secretion, suppress glucagon, and reduce blood sugar levels.

The molecule is the same, and the route is the difference. Ozempic is injected once a week. Rybelsus is swallowed once a day before breakfast, with nothing else for half an hour, because the SNAC absorption enhancer works only when the stomach is empty. In the US, Rybelsus is being discontinued: on June 4, 2026 the FDA listed all three strengths as discontinued, to be replaced by Ozempic tablets, the same semaglutide reformulated at 1.5, 4 and 9 mg and on sale since May 4, 2026. Under the shared label, 7 mg of Rybelsus corresponds to 4 mg of Ozempic tablets and 14 mg to 9 mg, and the label says the two are not substitutable milligram for milligram. On heart outcomes, SUSTAIN-6 found the injection superior to placebo for major cardiovascular events (HR 0.74). For the tablet, PIONEER 6 showed noninferiority (HR 0.79) and the later SOUL trial showed superiority (HR 0.86), which added a cardiovascular indication to the tablet label. The Ozempic pen costs $349 to $499 a month through NovoCare self-pay, and Ozempic tablets $149 to $299 by strength. The choice is between a daily tablet routine and a weekly injection.

Full Ozempic vs Rybelsus comparison →
MounjaroTirzepatide · Eli Lilly and Company

Injected, and a dual GIP/GLP-1 agonist. Glycemic and weight effect generally run higher

Mounjaro's tirzepatide activates both GIP and GLP-1 receptors — making it a "dual agonist" or "twincretin." For diabetes, this dual action powerfully lowers blood sugar by increasing insulin secretion and reducing glucagon.

Two diabetes drugs, neither approved for weight management, compared mostly by people who want the weight effect anyway. SURPASS-2 reported −11.2 kg at 40 weeks for Mounjaro; PIONEER 1 reported −3.7 kg at 26 weeks for Rybelsus 14 mg. These are different trials with different durations. In the US, Rybelsus is being discontinued and replaced by Ozempic tablets, which cost $149–$299 a month self-pay. Mounjaro lists at about $1,112 a month, with Lilly's savings card requiring commercial insurance. The practical difference is the dosing burden: a daily fast, or a weekly injection.

Full Mounjaro vs Rybelsus comparison →
TrulicityDulaglutide · Eli Lilly and Company

A weekly injection instead, with years of real-world safety data behind it

Dulaglutide is a long-acting GLP-1 receptor agonist engineered by fusing two modified GLP-1 peptide chains to a human IgG4 Fc fragment, which extends the half-life to about five days and allows once-weekly dosing.

Both are diabetes drugs, neither is approved for weight management, and the weight figures (−3.7 kg on Rybelsus 14 mg at 26 weeks in PIONEER 1, −2 to −3 kg on Trulicity) come from diabetes programs rather than obesity trials. Rybelsus needs the fasting window that oral semaglutide absorption requires; Trulicity is one weekly injection with no food rules. Each has an outcomes trial showing fewer major cardiac events: REWIND for dulaglutide and SOUL for oral semaglutide (HR 0.86). In the US, Rybelsus is being discontinued and replaced by Ozempic tablets, which cost $149–$299 a month self-pay. For most people the formulary makes this decision.

Full Trulicity vs Rybelsus comparison →

Drug facts on this page were last verified against each drug's FDA label and trial record.

Compare compounded Semaglutide providers

Compounded semaglutide sits at a middle figure of $199/month across 726 price points in the register, spanning $49 to $599. The partners below are ordered by our partner economics.

YourEra
compounded
Collective
compounded
MyDrHank
compounded
$249/mo
Visit Site
Embody
compounded

Compare compounded Tirzepatide providers

Compounded tirzepatide sits at a middle figure of $250/month across 697 price points in the register, spanning $69 to $849. The partners below are ordered by our partner economics.

Collective
compounded
Embody
compounded
$129/mo
Visit Site
MyDrHank
compounded
$349/mo
Visit Site
Eden
compounded
$129/mo
Visit Site

Compare every Rybelsus provider

Current price, verification status, product form and the states each seller ships to, all on one screen.

Frequently Asked Questions

The ones people usually weigh Rybelsus against are Ozempic, Mounjaro, Trulicity. Which of them fits turns on what you are being treated for — weight management or type 2 diabetes — on whether you want a needle or a tablet, on price, and on how well your gut copes. A prescriber can set all of that against your own history.
Compounded semaglutide sits at a middle figure of $199/month across 726 price points in the register — as a rule, a long way under brand list. What you are buying is not FDA- approved, and it is not the clinical equivalent of the branded product, so weigh a seller's verification before you commit.
That call belongs to a licensed prescriber, and it turns on how you are actually responding, what side effects you are carrying, what it costs, what your plan covers, and what you are being treated for. Take the comparisons on this page into that conversation as questions — they are not a stand-in for it.